Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest, whereas a second barrier is mediated by oncogene-induced senescence. The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [8]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Bartkova et al. 2006
In the citing paper
“Colon adenomas, which are stable precursor lesions of invasive colon cancer, were found to be negative for the proliferation marker Ki67 and positive for SA- β- gal 87,88 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“colon adenoma- derived samples also have elevated expression of p16 INK4a , HP1γ (an H3K9me3- enriched senescence- associated heterochromatin focus- promoting scaffold that connects H3K9 methyltransferases to Rb as another binding partner), and focal γH2AX expression, indicating enhanced DNA damage 87,89 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“In particular, E1A inhibits p53 phosphorylation at serine 15 (14), a hallmark of the activation of the DNA damage response during senescence (3, 12).”
From Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence (2009) · cites this paper as [3]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Self-citationCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Cited by
Items 101–200 of 1,016
Healing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence
Adams, P. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.021 · Cited by 326
Lecona, E., & Fernandez-Capetillo, O. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0034-3 · Cited by 325
The ATM protein kinase and cellular redox signaling: beyond the DNA damage response
Ditch, S., & Paull, T. T. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.10.002 · Cited by 324
Watanabe, S., Kawamoto, S., Ohtani, N., & Hara, E. (2017) · Cancer Science · doi:10.1111/cas.13184 · Cited by 321
Buisson, R., Boisvert, J. L., Benes, C. H., & Zou, L. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.029 · Cited by 316
ATR signalling: more than meeting at the fork
Nam, E. A., & Cortez, D. (2011) · Biochemical Journal · doi:10.1042/bj20102162 · Cited by 316
Target gene-independent functions of MYC oncoproteins
Baluapuri, A., Wolf, E., & Eilers, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0215-2 · Cited by 310
Cao, L., Xu, X., Bunting, S. F., Liu, J., Wang, R.-H., Cao, L. L., Wu, J. J., Peng, T.-N., Chen, J., Nussenzweig, A., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.037 · Cited by 309
Galanos, P., Vougas, K., Walter, D., Polyzos, A., Maya-Mendoza, A., Haagensen, E. J., Kokkalis, A., Roumelioti, F.-M., Gagos, S., Tzetis, M., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3378 · Cited by 308
Self-citationHolland, A. J., & Cleveland, D. W. (2012) · Nature Medicine · doi:10.1038/nm.2988 · Cited by 308
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
Staaf, J., Glodzik, D., Bosch, A., Vallon-Christersson, J., Reuterswärd, C., Häkkinen, J., Degasperi, A., Amarante, T. D., Saal, L. H., Hegardt, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0582-4 · Cited by 307
Beck, H., Nähse-Kumpf, V., Larsen, M. S. Y., O'Hanlon, K. A., Patzke, S., Holmberg, C., Mejlvang, J., Groth, A., Nielsen, O., Syljuåsen, R. G., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00412-12 · Cited by 306
“Recent data have also revealed that activated oncogenes can induce DNA replication stress, defined here as replication-associated DNA damage (2, 3, 10).”
BackgroundCell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
Viale, A., De Franco, F., Orleth, A., Cambiaghi, V., Giuliani, V., Bossi, D., Ronchini, C., Ronzoni, S., Muradore, I., Monestiroli, S., et al. (2009) · Nature · doi:10.1038/nature07618 · Cited by 305
The combined status of ATM and p53 link tumor development with therapeutic response
Jiang, H., Reinhardt, H. C., Bartkova, J., Tommiska, J., Blomqvist, C., Nevanlinna, H., Bartek, J., Yaffe, M. B., & Hemann, M. T. (2009) · Genes & Development · doi:10.1101/gad.1815309 · Cited by 304
“Recent studies have suggested that a DNA damage response similar to that seen following genotoxic chemotherapy may occur in human preneoplastic lesions (Bartkova et al. 2005, 2006; Gorgoulis et al. 2005; Halazonetis et al. 2008).”
BackgroundExploiting replicative stress to treat cancer
Dobbelstein, M., & Sørensen, C. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4553 · Cited by 302
Senescence from G2 arrest, revisited
Gire, V., & Dulić, V. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1000134 · Cited by 300
Biology of glucose metabolization in cancer cells
Fadaka, A., Ajiboye, B., Ojo, O., Adewale, O., Olayide, I., & Emuowhochere, R. (2017) · Journal of Oncological Sciences · doi:10.1016/j.jons.2017.06.002 · Cited by 300
Oncogene-induced senescence and tumour control in complex biological systems
Galluzzi, L., & Vitale, I. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-018-0102-y · Cited by 242
Jones, R. M., Mortusewicz, O., Afzal, I., Lorvellec, M., García, P., Helleday, T., & Petermann, E. (2013) · Oncogene · doi:10.1038/onc.2012.387 · Cited by 295
Self-citationThe presence of extra chromosomes leads to genomic instability
Passerini, V., Ozeri-Galai, E., de Pagter, M. S., Donnelly, N., Schmalbrock, S., Kloosterman, W. P., Kerem, B., & Storchová, Z. (2016) · Nature Communications · doi:10.1038/ncomms10754 · Cited by 293
“Mounting evidence shows that GIN and replication stress occur early in tumorigenesis, and many known oncogenes and oncogenic mutations act by triggering replication stress and subsequently genomic instability 9–11 .”
InfluentialHomologous recombination in cancer development, treatment and development of drug resistance
Helleday, T. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq064 · Cited by 291
Self-citationRegulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 288
Aging of the cells: Insight into cellular senescence and detection Methods.
Mohamad Kamal, N. S., Safuan, S., Shamsuddin, S., & Foroozandeh, P. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151108 · Cited by 287
Witkiewicz, A. K., Knudsen, K. E., Dicker, A. P., & Knudsen, E. S. (2011) · Cell Cycle · doi:10.4161/cc.10.15.16776 · Cited by 286
Aird, K. M., Zhang, G., Li, H., Tu, Z., Bitler, B. G., Garipov, A., Wu, H., Wei, Z., Wagner, S. N., Herlyn, M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.004 · Cited by 285
“In addition, senescence induced by oncogenic RAS is characterized by the DDR (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundMethodInfluentialWeyemi, U., Lagente-Chevallier, O., Boufraqech, M., Prenois, F., Courtin, F., Caillou, B., Talbot, M., Dardalhon, M., Al Ghuzlan, A., Bidart, J.-M., et al. (2012) · Oncogene · doi:10.1038/onc.2011.327 · Cited by 285
“One possibility is that the DNA damage response is triggered by excessive replication caused by a sustained oncogenic signal (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundInfluentialThe Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies
Knudsen, E. S., & Witkiewicz, A. K. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2016.11.006 · Cited by 285
F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage
Santra, M. K., Wajapeyee, N., & Green, M. R. (2009) · Nature · doi:10.1038/nature08011 · Cited by 284
Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy
Binet, F., Cagnone, G., Crespo-Garcia, S., Hata, M., Neault, M., Dejda, A., Wilson, A. M., Buscarlet, M., Mawambo, G. T., Howard, J. P., et al. (2020) · Science · doi:10.1126/science.aay5356 · Cited by 283
Kosar, M., Bartkova, J., Hubackova, S., Hodny, Z., Lukas, J., & Bartek, J. (2011) · Cell Cycle · doi:10.4161/cc.10.3.14707 · Cited by 283
Self-citationEmerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence
Xu, Y., Li, N., Xiang, R., & Sun, P. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.04.004 · Cited by 282
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
Dietlein, F., Thelen, L., & Reinhardt, H. C. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.06.003 · Cited by 280
Tubiana, M. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.12.016 · Cited by 280
DNA replication stress, genome instability and aging
Burhans, W. C., & Weinberger, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1059 · Cited by 279
“Replication stress was also recently implicated in cellular senescence, which protects against cancer, but promotes aging (5,7).”
BackgroundSignaling through cyclin D-dependent kinases
Choi, Y. J., & Anders, L. (2014) · Oncogene · doi:10.1038/onc.2013.137 · Cited by 278
The impact of replication stress on replication dynamics and DNA damage in vertebrate cells
Técher, H., Koundrioukoff, S., Nicolas, A., & Debatisse, M. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.46 · Cited by 277
Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability
Fagundes, R., & Teixeira, L. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.774845 · Cited by 276
BRAFE600 in benign and malignant human tumours
Michaloglou, C., Vredeveld, L. C. W., Mooi, W. J., & Peeper, D. S. (2008) · Oncogene · doi:10.1038/sj.onc.1210704 · Cited by 275
“Recent data reveal that cells undergoing oncogeneinduced senescence in vitro display signs of a DDR, which is causally involved in senescence induction (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007).”
BackgroundHubackova, S., Krejcikova, K., Bartek, J., & Hodny, Z. (2012) · Aging · doi:10.18632/aging.100520 · Cited by 272
ATM and ATR signaling at a glance
Awasthi, P., Foiani, M., & Kumar, A. (2015) · Journal of Cell Science · doi:10.1242/jcs.169730 · Cited by 271
Mammalian RAD52 Functions in Break-Induced Replication Repair of Collapsed DNA Replication Forks
Sotiriou, S. K., Kamileri, I., Lugli, N., Evangelou, K., Da-Ré, C., Huber, F., Padayachy, L., Tardy, S., Nicati, N. L., Barriot, S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.038 · Cited by 249
Self-citationmTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
Cam, H., Easton, J. B., High, A., & Houghton, P. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.030 · Cited by 266
Melanocytic nevi and melanoma: unraveling a complex relationship
Damsky, W. E., & Bosenberg, M. (2017) · Oncogene · doi:10.1038/onc.2017.189 · Cited by 248
The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma
Sheppard, K. E., & McArthur, G. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0259 · Cited by 265
“Increased p16 expression upon oncogenic signaling, DNA damage, and physiologic aging (22, 23) inhibits cell proliferation, and these”
BackgroundImpact of cellular senescence signature on ageing research
Sikora, E., Arendt, T., Bennett, M., & Narita, M. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.10.002 · Cited by 264
Cell fusion induced by ERVWE1 or measles virus causes cellular senescence
Chuprin, A., Gal, H., Biron-Shental, T., Biran, A., Amiel, A., Rozenblatt, S., & Krizhanovsky, V. (2013) · Genes & Development · doi:10.1101/gad.227512.113 · Cited by 262
“Persistent activation of a DNA damage response (DDR) is important for the establishment and maintenance of cellular senescence and can contribute to an increase in p53 levels (Bartkova et al. 2006; Di Micco et al. 2006; Moiseeva et al. 2006).”
BackgroundCDC6: from DNA replication to cell cycle checkpoints and oncogenesis
Borlado, L. R., & Méndez, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm268 · Cited by 262
“At least in one study, CDC6 overexpression in human primary fibroblasts triggered the DDR and drove the cells into senescence [97].”
BackgroundCellular senescence in vivo: a barrier to tumorigenesis
Prieur, A., & Peeper, D. S. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.007 · Cited by 260
ATM is down-regulated by N-Myc–regulated microRNA-421
Hu, H., Du, L., Nagabayashi, G., Seeger, R. C., & Gatti, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907763107 · Cited by 260
Robust, universal biomarker assay to detect senescent cells in biological specimens
Evangelou, K., Lougiakis, N., Rizou, S. V., Kotsinas, A., Kletsas, D., Muñoz‐Espín, D., Kastrinakis, N. G., Pouli, N., Marakos, P., Townsend, P., et al. (2017) · Aging Cell · doi:10.1111/acel.12545 · Cited by 259
“S3, Appendix S2; Bartkova et al., 2006; Liontos et al., 2007, 2009; Georgakopoulou et al., 2013; Galanos et al., 2016; Liakou et al., 2016; Petrakis et al., 2016).”
BackgroundSelf-citationCellular senescence and SASP in tumor progression and therapeutic opportunities
Dong, Z., Luo, Y., Yuan, Z., Tian, Y., Jin, T., & Xu, F. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02096-7 · Cited by 259
“OIS is also associated with signs of DNA replication stress, which can cause DSBs and genomic instability in human precancerous lesions [18, 19].”
BackgroundGut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
Okumura, S., Konishi, Y., Narukawa, M., Sugiura, Y., Yoshimoto, S., Arai, Y., Sato, S., Yoshida, Y., Tsuji, S., Uemura, K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25965-x · Cited by 259
Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perils
Torti, D., & Trusolino, L. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100176 · Cited by 246
“…the DNA damage response machinery, which activates the prototypical effector ataxia telangiectasia mutated (ATM); this converges on either p53 or p21, triggering the proliferation blockade that typifies the senescent phenotype (Bartkova et al, 2006; Di Micco et al, 2006; Halazonetis et al, 2008).”
BackgroundElucidating Distinct Roles for NF1 in Melanomagenesis
Maertens, O., Johnson, B., Hollstein, P., Frederick, D. T., Cooper, Z. A., Messiaen, L., Bronson, R. T., McMahon, M., Granter, S., Flaherty, K., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0313 · Cited by 258
Oncogene-induced senescence: the bright and dark side of the response
Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.07.013 · Cited by 257
“Perhaps, the best proof of the physiological value of cellular senescence stems from human premalignant lesions which demonstrate the highest values of senescence-associated markers [16 ,28 ,34 ,35,36 ,37 ,38] and progressively decline as the lesions progress to full-blown cancer [38].”
BackgroundSelf-citationp53 and ribosome biogenesis stress: The essentials
Golomb, L., Volarevic, S., & Oren, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.014 · Cited by 242
Cause and Consequence of Cancer/Testis Antigen Activation in Cancer
Whitehurst, A. W. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140326 · Cited by 250
The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks
Bansbach, C. E., Bétous, R., Lovejoy, C. A., Glick, G. G., & Cortez, D. (2009) · Genes & Development · doi:10.1101/gad.1839909 · Cited by 251
“These kinases are activated in premalignant lesions presumably due to replication stress caused by activated oncogenes or inactivation of tumor suppressors (Bartkova et al. 2005, 2006; Gorgoulis et al. 2005).”
BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
Hawkins, C., Walker, E., Mohamed, N., Zhang, C., Jacob, K., Shirinian, M., Alon, N., Kahn, D., Fried, I., Scheinemann, K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0034 · Cited by 250
Radiation-induced cancer: a modern view
Shah, D. J., Sachs, R. K., & Wilson, D. J. (2012) · The British Journal of Radiology · doi:10.1259/bjr/25026140 · Cited by 241
Vendetti, F. P., Lau, A., Schamus, S., Conrads, T. P., O’Connor, M. J., & Bakkenist, C. J. (2015) · Oncotarget · doi:10.18632/oncotarget.6247 · Cited by 239
Nuclear initiated NF-κB signaling: nemo and ATM take center stage
Miyamoto, S. (2011) · Cell Research · doi:10.1038/cr.2010.179 · Cited by 253
Physiological and pathological consequences of cellular senescence
Burton, D. G. A., & Krizhanovsky, V. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1691-3 · Cited by 253
“Although initially limited to in vitro studies, numerous findings suggest that OIS might be mediated, at least partially, by the induction of DNA damage, often associated with elevated reactive oxygen species (ROS) levels [10–14].”
BackgroundThe role of microRNAs in colorectal cancer
Schetter, A. J., Okayama, H., & Harris, C. C. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318258b78f · Cited by 252
The ATM Kinase Induces MicroRNA Biogenesis in the DNA Damage Response
Zhang, X., Wan, G., Berger, F. G., He, X., & Lu, X. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.020 · Cited by 239
“Moreover, accumulating evidence from recent studies suggested that oncogeneinduced DNA damage signaling serves as an anticancer barrier in tumorigenesis, underpinning a critical role of ATM in tumor suppression (Bartkova et al., 2005, 2006; Halazonetis et al., 2008).”
NKG2D ligands: key targets of the immune response
González, S., López-Soto, A., Suarez-Alvarez, B., López-Vázquez, A., & López-Larrea, C. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.04.007 · Cited by 241
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy
Fang, Y., McGrail, D. J., Sun, C., Labrie, M., Chen, X., Zhang, D., Ju, Z., Vellano, C. P., Lu, Y., Li, Y., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.05.001 · Cited by 233
Cellular Senescence: Molecular Mechanisms, In Vivo Significance, and Redox Considerations
Muller, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2104 · Cited by 238
“Fibro-blasts induced into premature senescence by oncogenic Ras produce elevated intracellular levels of ROS (187, 234), with associated damage to DNA (single-and double-strand breaks) triggering cell-cycle arrest (23, 98, 258, 412).”
Squatrito, M., Brennan, C. W., Helmy, K., Huse, J. T., Petrini, J. H., & Holland, E. C. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.034 · Cited by 238
“The DDR acts as a barrier against tumor progression, where precancerous lesions must inactivate p53 or other elements of the DDR to proceed to amore aggressive status (Bartkova et al., 2005, 2006).”
BackgroundYe, X., Zerlanko, B., Kennedy, A., Banumathy, G., Zhang, R., & Adams, P. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.034 · Cited by 228
NADPH oxidase 4 is an oncoprotein localized to mitochondria
Graham, K. A., Kulawiec, M., Owens, K. M., Li, X., Desouki, M. M., Chandra, D., & Singh, K. K. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.3.12207 · Cited by 236
Nikitin, P. A., Yan, C. M., Forte, E., Bocedi, A., Tourigny, J. P., White, R. E., Allday, M. J., Patel, A., Dave, S. S., Kim, W., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.11.004 · Cited by 235
“Genetic experiments have identified critical roles for ATM and Chk2 in mediating oncogene-induced senescence and tumor suppression (Bartkova et al., 2006; Pusapati et al., 2006; Stracker et al., 2008).”
A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism
Pribluda, A., Elyada, E., Wiener, Z., Hamza, H., Goldstein, R. E., Biton, M., Burstain, I., Morgenstern, Y., Brachya, G., Billauer, H., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.005 · Cited by 239
“Mechanistically, OIS is the best-characterized process; similar to replicative senescence, OIS induces DDR, with subsequent activation of p53 and p21, imposing growth arrest (Bartkova et al., 2006).”
BackgroundInfluentialGilad, O., Nabet, B. Y., Ragland, R. L., Schoppy, D. W., Smith, K. D., Durham, A. C., & Brown, E. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2286 · Cited by 228
Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer.
Sulli, G., Di Micco, R., & di Fagagna, F. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3344 · Cited by 238
Replication licensing and cancer — a fatal entanglement?
Blow, J. J., & Gillespie, P. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2500 · Cited by 228
Reinhardt, H. C., Hasskamp, P., Schmedding, I., Morandell, S., van Vugt, M. A. T. M., Wang, X., Linding, R., Ong, S.-E., Weaver, D., Carr, S. A., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.018 · Cited by 238
“, positive nuclear gH2AX staining), likely as a consequence of oncogenic stress (Figure 2G) (Bartkova et al., 2006; Di Micco et al., 2006).”
Alzu, A., Bermejo, R., Begnis, M., Lucca, C., Piccini, D., Carotenuto, W., Saponaro, M., Brambati, A., Cocito, A., Foiani, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.041 · Cited by 234
Loo, T. M., Miyata, K., Tanaka, Y., & Takahashi, A. (2020) · Cancer Science · doi:10.1111/cas.14266 · Cited by 232
James, E. L., Michalek, R. D., Pitiyage, G. N., de Castro, A. M., Vignola, K. S., Jones, J., Mohney, R. P., Karoly, E. D., Prime, S. S., & Parkinson, E. K. (2015) · Journal of Proteome Research · doi:10.1021/pr501221g · Cited by 231
Lemée, F., Bergoglio, V., Fernandez-Vidal, A., Machado-Silva, A., Pillaire, M.-J., Bieth, A., Gentil, C., Baker, L., Martin, A.-L., Leduc, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910759107 · Cited by 216
“We also show in MCF7 breast cancer cells that depletion of Cyclin E did not alter POLQ expression, indicating that POLQ expression is not stimulated in response to the increased replication stress caused by the Cyclin E oncogene (29).”
BackgroundDNA replication stress: Causes, resolution and disease
Mazouzi, A., Velimezi, G., & Loizou, J. I. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.030 · Cited by 211
“[33] J.”
BackgroundSuram, A., Kaplunov, J., Patel, P. L., Ruan, H., Cerutti, A., Boccardi, V., Fumagalli, M., Di Micco, R., Mirani, N., Gurung, R. L., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.132 · Cited by 227
“Since fragile sites are particularly sensitive to oncogene-induced DNA replication stress (Bartkova et al , 2006; Di Micco et al , 2006), and telomeres resemble fragile sites (Martinez et al , 2009; Sfeir et al , 2009; Ye et al , 2010), we asked whether oncogenic Ras causes DNA replication stress…”
Deregulated Overexpression of hCdt1 and hCdc6 Promotes Malignant Behavior
Liontos, M., Koutsami, M., Sideridou, M., Evangelou, K., Kletsas, D., Levy, B., Kotsinas, A., Nahum, O., Zoumpourlis, V., Kouloukoussa, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2837 · Cited by 217
Self-citationNucleophosmin and its complex network: a possible therapeutic target in hematological diseases
Colombo, E., Alcalay, M., & Pelicci, P. G. (2011) · Oncogene · doi:10.1038/onc.2010.646 · Cited by 210
“, 2004 ), or to repression, as for the activating protein transcription factor 2 (AP2α) (”
BackgroundMolecular mechanisms of natural killer cell activation in response to cellular stress
Chan, C. J., Smyth, M. J., & Martinet, L. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.26 · Cited by 213
“Thus, premature senescence is an important barrier against malignant transformation.(59) Upon engagement of the senescence program, although cells are in growth arrest, they remain metabolically active and can produce many proinflammatory cytokines, as well as upregulate adhesion molecules and activating ligands to al…”
BackgroundCremona, C. A., & Behrens, A. (2014) · Oncogene · doi:10.1038/onc.2013.275 · Cited by 204
The detection and implication of genome instability in cancer
Pikor, L., Thu, K., Vucic, E., & Lam, W. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9429-5 · Cited by 203
“These theories, which include the mutator phenotype, DNA damage-induced replication stress, telomere dysfunction, and mitotic checkpoint failure [5–11], vary principally in their supposition of how early in tumorigenesis instability occurs, mechanisms leading to sequence level alteration, and whether instability initi…”
The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology
Huff, W. X., Kwon, J. H., Henriquez, M., Fetcko, K., & Dey, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112810 · Cited by 217
“Oncogene-induced senescence is one of the well-described mechanisms for premature senescence [87,88].”
BackgroundKarst, A. M., Jones, P. M., Vena, N., Ligon, A. H., Liu, J. F., Hirsch, M. S., Etemadmoghadam, D., Bowtell, D. D. L., & Drapkin, R. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2247 · Cited by 208
Oncogene-induced senescence: a double edged sword in cancer
Liu, X.-L., Ding, J., & Meng, L.-H. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.198 · Cited by 190
Inflammation and colorectal cancer, when microbiota-host mutualism breaks
Candela, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i4.908 · Cited by 197
Targeting the RB-pathway in Cancer Therapy
Knudsen, E. S., & Wang, J. Y. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0787 · Cited by 203
“In addition to cyclin D1 and RB, p16ink4a is implicated in enforcing senescence-like growth arrest in response to the DNA damage (8).”
BackgroundCellular senescence in cancer: from mechanisms to detection
Ou, H., Hoffmann, R., González‐López, C., Doherty, G. J., Korkola, J. E., & Muñoz‐Espín, D. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12807 · Cited by 190
Herdy, J. R., Traxler, L., Agarwal, R. K., Karbacher, L., Schlachetzki, J. C. M., Boehnke, L., Zangwill, D., Galasko, D., Glass, C. K., Mertens, J., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.11.010 · Cited by 208
Marqués-Torrejón, M. Á., Porlan, E., Banito, A., Gómez-Ibarlucea, E., Lopez-Contreras, A. J., Fernández-Capetillo, Ó., Vidal, A., Gil, J., Torres, J., & Fariñas, I. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.001 · Cited by 201
“Given that oncogenes are known to induce RS (Bartkova et al., 2006; Di Micco et al., 2006), Sox2-induced RS might easily be related to its oncogenic role (Gangemi et al.”
BackgroundDelayed kinetics of DNA double‐strand break processing in normal and pathological aging
Sedelnikova, O. A., Horikawa, I., Redon, C., Nakamura, A., Zimonjic, D. B., Popescu, N. C., & Bonner, W. M. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2007.00354.x · Cited by 207
BRAF Signaling and Targeted Therapies in Melanoma
Dhomen, N., & Marais, R. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.04.001 · Cited by 195
Barascu, A., Le Chalony, C., Pennarun, G., Genet, D., Imam, N., Lopez, B., & Bertrand, P. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.492 · Cited by 206
“The molecular causes of the CNS demyelination and neurological defects in A-T remain puzzling (Barzilai et al , 2008; Biton et al , 2008).”
Cosme‐Blanco, W., Shen, M., Lazar, A. J. F., Pathak, S., Lozano, G., Multani, A. S., & Chang, S. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7400937 · Cited by 205
“Late-generation Terc / mice, which are telomerase deficient and have short telomeres, show elevated p53-dependent apoptosis in highly proliferative cellular compartments, such as the testis and bone marrow (Blasco et al, 1997; Rudolph et al, 1999).”
Background
Metadata
- Authors
- Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C. L., Dyrskjot, L., Ørntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T. D., Bartek, J., & Gorgoulis, V. G.
- Affiliations
- The Wistar Institute (US)
- National and Kapodistrian University of Athens (GR)
- National Centre of Scientific Research "Demokritos" (GR)
- Stockholm University (SE)
- University of Ioannina (GR)
- National Hellenic Research Foundation (GR)
- University of Pennsylvania (US)
- Danish Cancer Society (DK)
- Copenhagen University Hospital (DK)
- Aarhus University Hospital (DK)
- Corresponding author
- Halazonetis, Thanos D.
- ORCID
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 633-637
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2041156660
- Cited by
- 1,986
- References
- 30
- Citations by year
- 2026: 35 · 2025: 74 · 2024: 65 · 2023: 92 · 2022: 74 · 2021: 96 · 2020: 88 · 2019: 83 · 2018: 108 · 2017: 100 · 2016: 122 · 2015: 88 · 2014: 134 · 2013: 129 · 2012: 132
- FWCI
- 65.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- oncogene-induced senescence, DNA damage response, replication stress, DNA double-strand breaks, ATM kinase, precancerous lesions, senescence markers, tumor progression, apoptosis
- MeSH terms
- Animals, Cell Line, Cell Transformation, Neoplastic, DNA, DNA Damage, DNA Replication, Humans, Neoplasm Invasiveness, Nuclear Proteins, Oncogenes, Precancerous Conditions, Genes, mos, Cellular Senescence, Cell Cycle Proteins, Cyclin E, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.